Related Experiment Video
Updated: Aug 14, 2026
06:48
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
Retinal gene therapy 1998: summary of a workshop
1Departments of Ophthalmology and Molecular Genetics, University of Florida, Gainesville, FL 32610, USA. hauswrth@eye1.eye.ufl.edu
Molecular Vision
|July 24, 1998
Summary
The 1998 Workshop on Retinal Gene Therapy explored gene therapy for retinal diseases. Experts discussed candidate diseases, vector design, animal models, and human trial considerations for future treatments.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- The 1998 Workshop on Retinal Gene Therapy convened experts from academia, industry, and foundations.
- The workshop aimed to evaluate the therapeutic potential of gene therapy for various retinal diseases.
Framework:
- Discussions covered identifying suitable retinal diseases for gene therapy.
- Key topics included specific retinal degenerations and general neuronal survival mechanisms.
- The design and application of viral and retroviral vectors for controlled gene expression were examined.
Implementation:
- The use of animal models for retinal degeneration and related therapies was a central theme.
- Considerations for human trials, including ethical and logistical aspects, were thoroughly debated.
- Lessons learned from prior human gene therapy investigations were shared.
Implications:
- The workshop highlighted the critical role of industry in advancing both basic and clinical research in retinal gene therapy.
- Alternatives to gene therapy were also explored, providing a comprehensive overview of treatment strategies.
- The findings inform ongoing research and development in the field of ocular genetic medicine.
